Facebook
Twitter
LinkedIn
ForwardPCMH 2025 Blood Pressure Control and Asthma Medication Ratio Sprint - Session #1
Members of the healthcare team will develop a deeper understanding of the context and quality improvement framework for the 2025 Blood Pressure Control & Athsma Medication Ration sprint, including HEDIS measures and a Hypertension Change Package. Particpants will also engage in facilitated peer-to-peer learning around each PCMH's priority interventions and quality improvement work.
Agenda:
1:00 p.m. to 1:10 p.m. – Welcome & Presentation of the overall plan for the 2025 sprint, including goals, the description of the measure, and the quality improvement framework
- Share context for the measures.
- Describe HEDIS measures, Controlling High Blood Pressure and Asthma Medication Ratio
- Controlling High Blood Pressure assesses the percentage of members ages 18− 85 years who had a diagnosis of hypertension (HTN) and whose blood pressure was adequately controlled (<140/90 mm Hg) during the measurement year
- Asthma Medication Ratio assesses the percentage of members ages 5−64 years who were identified as having persistent asthma and had a ratio of controller medications to total asthma medications of 0.50 or greater during the measurement year.
1:10 p.m. to 1:20 p.m. – Q&A
1:20 p.m. to 1:40 p.m. – Peer to Peer Sharing
Breakout rooms to discuss root causes and associated interventions
- Two dedicated to BP
- One dedicated to Asthma
1:40 p.m. to 1:50 p.m. Group Report Outs
1:50 p.m. to 2:20 p.m. –Hypertension Change Package with Q&A– Debra McGrath, FNP, D-NP, President, DPM Healthcare Consulting
2:20 p.m. to 2:30 p.m. – Sprint Timeline, Next Steps & Evaluation
Target Audience
Nurse
Physician
Social Worker
Learning Objectives
• Establish a shared understanding of the 2025 PCMH Sprint goals and framework for addressing blood pressure control and/or asthma medication ratio.
• Define the key intervention each PCMH is implementing and next steps for making progress.
• Identify the root cause(s) to address as part of each respective key intervention.
Additional Information
| Attachment | Size |
|---|---|
 Audience Disclosure slides (001.5)_4.pptx | 460.12 KB |
 Draft Agenda_Feb18_Asthma_BP_HealthChoices PCMH Learning Network.docx | 51.23 KB |
Members of the healthcare team will develop a deeper understanding of the context and quality improvement framework for the 2025 Blood Pressure Control & Athsma Medication Ration sprint, including HEDIS measures and a Hypertension Change Package. Particpants will also engage in facilitated peer-to-peer learning around each PCMH's priority interventions and quality improvement work.
Agenda:
1:00 p.m. to 1:10 p.m. – Welcome & Presentation of the overall plan for the 2025 sprint, including goals, the description of the measure, and the quality improvement framework
- Share context for the measures.
- Describe HEDIS measures, Controlling High Blood Pressure and Asthma Medication Ratio
- Controlling High Blood Pressure assesses the percentage of members ages 18− 85 years who had a diagnosis of hypertension (HTN) and whose blood pressure was adequately controlled (<140/90 mm Hg) during the measurement year
- Asthma Medication Ratio assesses the percentage of members ages 5−64 years who were identified as having persistent asthma and had a ratio of controller medications to total asthma medications of 0.50 or greater during the measurement year.
1:10 p.m. to 1:20 p.m. – Q&A
1:20 p.m. to 1:40 p.m. – Peer to Peer Sharing
Breakout rooms to discuss root causes and associated interventions
- Two dedicated to BP
- One dedicated to Asthma
1:40 p.m. to 1:50 p.m. Group Report Outs
1:50 p.m. to 2:20 p.m. –Hypertension Change Package with Q&A– Debra McGrath, FNP, D-NP, President, DPM Healthcare Consulting
2:20 p.m. to 2:30 p.m. – Sprint Timeline, Next Steps & Evaluation
Robert Ferguson, MPH, Chief Policy Officer, Pittsburgh Regional Health Initiative
In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and The Jewish Healthcare Foundation. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
As a Jointly Accredited Organization, University of Pittsburgh is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. University of Pittsburgh maintains responsibility for this course. Social workers completing this course receive 1.5 continuing education credits.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 1.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.50 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.50 ASWB
- 1.50 Attendance